Profiles in Pharma - March 8, 2017
“We have to embrace the new era of diabetes care”
Mads Krogsgaard Thomsen, Executive Vice President and Chief Science Officer at Novo Nordisk, talks about the Danish pharma giant’s drug-development strategy, the new era of diabetes care and his 25 year-long passion for his job. The changing diabetes market, with increasing competition and high prices for diabetes products in the US, has made the world’s […]
Profiles in Science - March 8, 2017
“My basic personality is more like a discoverer”
Sirpa Jalkanen is a professor in the Academy of Finland, board member of Orion, and cofounder of BioTie Therapies and Faron Pharmaceuticals. BioTie Therapies and Faron Pharmaceuticals develop drugs for inflammation and immune-related conditions. In 2016, BioTie was acquired by Acorda Therapeutics. How did you turn basic research findings into companies? “When we returned from […]
Profiles in Pharma - February 16, 2017
From regulator to pharma industry specialist
Dr. Thomas Lönngren, former head of the EMA and today a pharmaceutical consultant, provides some insights on the aftermath of Brexit, describes current challenges the industry is facing and takes a short walk down memory lane on his career journey. The summer of 2016 will be remembered for many things; record temperatures, terrorist acts in […]
Profiles in MedTech - January 20, 2017
Habib Frost: “I was compelled to find a better way”
Habib Frost, MD, could not get over the helplessness he felt as a young emergency medicine intern in Denmark seeing two young people die in the same day from cardiac arrest, despite having access to skilled providers and the latest technology.
Nobel Prize Laureate - December 20, 2016
Bernard L. Feringa: An ambassador for science
Bernard L. Feringa is pioneer in the field of molecular engines and he strives to inspire his students, stimulate their creativity and help them appreciate the beauty of nature.
Nobel Prize Laureate - December 20, 2016
Yoshinori Ohsumi: “Still we have so many questions”
The 2016 Nobel Prize in Physiology or Medicine highlights a process that is integral to aging, cancer, and infectious disease, but has not been well known outside of cell biology.
